Hypothesis

The circadian clock protects genome integrity by driving rhythmic NAD+ biosynthesis, which in turn times sirtuin activity to peak DNA repair and mitochondrial quality control. When circadian amplitude declines with age, NAD+ oscillations flatten, causing chronic sub‑optimal sirtuin activation, accumulation of DNA damage, and accelerated senescence. Restoring NAD+ rhythms through timed supplementation will re‑synchronize sirtuin‑dependent repair pathways and delay aging phenotypes more effectively than constant NAD+ elevation.

Mechanistic Rationale

1. Circadian control of NAD+ – The rate‑limiting enzyme NAMPT is a direct transcriptional target of CLOCK:BMAL1, producing a ~24‑hour NAD+ rhythm that peaks toward the early subjective night in mammals[1][2]. This rhythm supplies the essential cofactor for SIRT1, SIRT3, and SIRT6, which deacetylate histones, DNA repair factors (e.g., Ku70, PARP1), and mitochondrial enzymes.
2. Sirtuin‑dependent genome maintenance – SIRT1 promotes homologous recombination and non‑homologous end joining; SIRT6 facilitates base excision repair and telomere chromatin stability; SIRT3 regulates mitochondrial ROS detoxification[3]. Their enzymatic activity follows NAD+ availability, creating a temporal window of high repair capacity each cycle.
3. Age‑related damping – In aged tissues, NAMPT expression loses amplitude, NAD+ peaks blunt, and sirtuin activity becomes constitutively low[4]. This leads to inefficient repair, persistent γ‑H2AX foci, and mitochondrial ROS spikes that feed back to further suppress clock gene expression via oxidative modification of BMAL1[5].
4. Vicious loop – Senescent cells secrete SASP factors that alter NAD+ metabolizing enzymes (e.g., CD38 upregulation), deepening NAD+ depletion and reinforcing circadian disruption[6].

Thus, the circadian‑NAD+-sirtuin axis functions as a temporal firewall: rhythmic NAD+ pulses gate periodic, high‑fidelity genome maintenance; loss of rhythm converts this gate into a permanently closed, leaky barrier.

Testable Predictions

• Prediction 1: In young wild‑type mice, NAD+ levels, SIRT1/3/6 activity, and markers of DNA repair (e.g., RAD51 foci) will show coherent 24‑hour peaks that align with the NAD+ zenith.
• Prediction 2: In aged mice, the amplitude of NAD+ and sirtuin activity rhythms will be reduced by >50% compared with young, correlating with increased 8‑oxo‑dG and senescent cell burden.
• Prediction 3: Acute NAD+ precursor (e.g., NR) administered at the circadian time of NAD+ peak (ZT6) will restore sirtuin activity peaks and reduce DNA damage markers, whereas the same dose given at trough (ZT18) will have minimal effect.
• Prediction 4: Genetic rescue of NAMPT rhythmicity (using a inducible, clock‑driven NAMPT transgene) in aged mice will re‑establish NAD+ oscillations, improve SIRT6‑dependent telomere stability, and extend healthspan without altering total NAD+ pool size.

Experimental Approach

1. In vivo rhythm profiling – Collect liver, muscle, and SCN tissues from 3‑month and 24‑month mice every 4 h over 48 h; quantify NAD+ (LC‑MS), SIRT1/3/6 activity (fluorometric deacetylase assays), and DNA damage (γ‑H2AX, COMET).
2. Timed NAD+ supplementation – Treat aged mice with NR (300 mg/kg/day) either continuously or in a single bolus at ZT6 or ZT18 for 4 weeks; assess changes in NAD+ rhythm amplitude, senescence (p16^INK4a^, SA‑β‑gal), and frailty index.
3. Genetic rescue – Generate a Bmal1‑driven, doxycycline‑inducible NAMPT allele; induce expression in aged mice for 2 weeks; monitor NAD+ rhythms, SIRT6 chromatin binding at telomeres (ChIP‑qPCR), and lifespan.
4. Falsification – If timed NAD+ delivery fails to improve repair metrics or if restoring NAMPT rhythmicity does not ameliorate DNA damage despite normalizing NAD+ levels, the hypothesis would be refuted, indicating that circadian NAD+ oscillations are not the limiting gatekeeper of sirtuin‑mediated genome maintenance.

This framework positions the circadian‑NAD+-sirtuin circuit as a reparative gate whose temporal precision, rather than mere metabolite abundance, determines the efficacy of the anti‑aging firewall.